GobyMeds vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
GobyMeds beats Hims overall, scoring 8.4/10 vs 7.9/10. GobyMeds is more affordable at $169/mo vs $199/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose Hims for men who want a well-known publicly-traded brand and fda-appr.
A side-by-side look at GobyMeds and Hims to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
GobyMeds
#3 of 52Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.
Visit GobyMedsHims
#9 of 52The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit Hims| Feature | GobyMeds | Hims |
|---|---|---|
| Our Score | 8.4/10 | 7.9/10 |
| Starting Price | $169/mo | $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors |
| Ranking | #3 | #9 |
| Get started | Visit GobyMeds | Visit Hims |
Pros & Cons Compared
GobyMeds
Pros
- +$169/mo standard monthly rate, or $99/mo on the 3-month starter bundle, among the most affordable for a full-service compounded program
- +Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
- +Modern patient portal with real-time order tracking and easy provider messaging
- +Quick onboarding, most patients approved and shipped within 48 hours of enrollment
Cons
- −Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story
- −Newer company with less track record than established players like Ro or Hims
- −No insurance billing and no superbills for FSA/HSA reimbursement
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
- −Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Our Verdict
GobyMeds edges out Hims with a score of 8.4/10 vs 7.9/10. If budget is your priority, GobyMeds starts at $169/mo compared to Hims's $199/mo. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.
Still undecided? Editor's Featured Pick
Yucca Health
$146/mo · 7.7/10 · Compounded
If neither GobyMeds nor Hims feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing GobyMeds or Hims tend to look at next.
- GobyMeds vs SynergyRx$199/mo
- GobyMeds vs Oak Longevity$133/mo
- GobyMeds vs Found$129/mo
- Hims vs MEDVi$179/mo
- Hims vs Hers$199/mo
- Hims vs Shed$199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.